Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1986;8:83-88

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gavras, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gavras, H.

Hypertension, Vol 8, 83-88, Copyright © 1986 by American Heart Association


ARTICLES

How does salt raise blood pressure? A hypothesis

H Gavras

Existing data in the literature indicate that alpha 2-adrenergic receptor agonists have a profound hypotensive action, that sodium attenuates the affinity of alpha 2-adrenergic receptors for agonists, that the location of these receptors in the central nervous system is mainly at the sites of cardiovascular regulation, and that these sites exert a constant tonic inhibition of sympathetic vasoconstrictor tone. This article proposes the theory that sodium exerts its hypertensive action by decreasing the state of affinity of the alpha 2-adrenergic receptors of the central nervous system for locally occurring agonist neurotransmitters, which results in disinhibition of sympathoinhibitory neurons and leads to the hyperadrenergic state characteristic of salt- induced hypertension.


This article has been cited by other articles:


Home page
HypertensionHome page
K. P. Makaritsis, C. Johns, I. Gavras, and H. Gavras
Role of {alpha}2-Adrenergic Receptor Subtypes in the Acute Hypertensive Response to Hypertonic Saline Infusion in Anephric Mice
Hypertension, February 1, 2000; 35(2): 609 - 613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. R. Brown, S.-G. Li, J. E. Lawler, and D. C. Randall
Sympathetic control of BP and BP variability in borderline hypertensive rats on high- vs. low-salt diet
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R650 - R657.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. P. Makaritsis, C. Johns, I. Gavras, J. D. Altman, D. E. Handy, M. R. Bresnahan, and H. Gavras
Sympathoinhibitory Function of the {alpha}2A-Adrenergic Receptor Subtype
Hypertension, September 1, 1999; 34(3): 403 - 407.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. P. Makaritsis, D. E. Handy, C. Johns, B. Kobilka, I. Gavras, and H. Gavras
Role of the {alpha}2B-Adrenergic Receptor in the Development of Salt-Induced Hypertension
Hypertension, January 1, 1999; 33(1): 14 - 17.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. R. Weir, D. R. Dengel, M. T. Behrens, and A. P. Goldberg
Salt-Induced Increases in Systolic Blood Pressure Affect Renal Hemodynamics and Proteinuria
Hypertension, June 1, 1995; 25(6): 1339 - 1344.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
R. R. Townsend and O. B. Holland
Combination of Converting Enzyme Inhibitor With Diuretic for the Treatment of Hypertension
Arch Intern Med, June 1, 1990; 150(6): 1175 - 1183.
[Abstract] [PDF]